Furthermore, as seen in AT from T2D versus nondiabetic individuals, ZMAT3 expression is increased together with senescence markers in human liver as the disease progresses from NAFLD to NASH (77), indicating that this gene may also be involved in regulating hepatocyte senescence in human NAFLD/NASH. This evidence concerns the gene ZMAT3 and metabolic dysfunction-associated steatotic liver disease.